Search | Search by Center | Search by Source | Keywords in Title
Chan K, Lai MN, Groessl EJ, Hanchate A, Hernandez A, Wong JB, Clark JA, Asch SM, Gifford AL, Ho S. Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration. [Abstract]. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2011 Nov 1; 14(7):A269-A270.